TuHURA Biosciences (HURA) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for TuHURA Biosciences
Is TuHURA Biosciences a buy right now? The alternative data says hold. This HURA stock analysis is built on the 25+ alternative data signals AltIndex tracks on TuHURA Biosciences every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 48/100: a Hold. The stock trades at $1.97 with a $125M market cap.
The data leans positive over the past 90 days — web traffic up 6.5% to 5K monthly visits — but the move hasn’t been broad enough to lift HURA into buy territory yet.
HURA’s broader alt-data profile also covers headcount (32 employees, according to LinkedIn), X followers (195), and sentiment (100/100). Every signal links to its own page with full history, the HURA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on HURA is just below.
TuHURA Biosciences AI Stock Analysis
TuHURA Biosciences is a notable player in the biotechnology sector, known for its advancements in genetic research and innovative therapies. The company has been committed to the development of groundbreaking treatments, primarily focusing on genetic disorders and cancer therapies.
Analysis generated October 2, 2026.
Recent TuHURA Biosciences Stock Alerts
|
TuHURA Biosciences | October 1 Price is down by -6.2% in the last 24h. |
|
TuHURA Biosciences | August 24 Price is up by 6% in the last 24h. |
|
TuHURA Biosciences | August 19 Price is up by 6% in the last 24h. |
|
TuHURA Biosciences | August 17 Price is down by -6.5% in the last 24h. |
TuHURA Biosciences Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | 6.5% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 32 | 3.0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 2 | 100.0% | |
| Stocktwits Mentions | 7 | 75.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 15K | 0% | |
| X Followers | 195 | 0% | |
| Facebook Followers | 31 | 0% | |
| Facebook Engagement | 0 | N/A |
About TuHURA Biosciences (HURA)
TuHURA Biosciences Inc is a leading biotechnology firm focused on pioneering immunotherapy solutions aimed at revolutionizing cancer and autoimmune disease treatment. With a robust pipeline driven by extensive scientific research, the company is dedicated to unlocking the full potential of the human immune system to enhance patient outcomes significantly. TuHURA's strategic partnerships and commitment to innovative technologies position it well for sustainable growth and value creation in the fast-evolving biopharmaceutical sector. As it advances its research and development activities, TuHURA is set to be a transformative player in the future of healthcare.
| Price | $1.97 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $125M |
| Year Range | $0 – $3 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest TuHURA Biosciences News
View more → |
TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) TechnologyOctober 5 - PRNewswire |
 |
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate UpdateAugust 14 - PRNewswire |
 |
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related CancersJune 15 - PRNewswire |
 |
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate UpdateMay 15 - PRNewswire |
|
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor ConferenceMay 12 - PRNewswire |
See TuHURA Biosciences’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for HURA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREETuHURA Biosciences Earnings & Financial Performance
View all earnings →TuHURA Biosciences Insider Trading Activity
View all →| No recent insider transactions on file. |
TuHURA Biosciences Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Laurel Lee |
Aug 11, 25 | Buy | $75K+ |
| Laurel Lee |
Jan 8, 25 | Buy | $8K+ |
Stocks Similar to TuHURA Biosciences
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Tonix PharmaceuticalsTNXP |
$7.14 2.2% | $125M | 44 |
 |
Lixte Biotech HldgsLIXT |
$7.21 6.0% | $125M | 43 |
 |
NRx PharmaceuticalsNRXP |
$2.84 0.5% | $123M | 50 |
 |
Spruce BiosciencesSPRB |
$43.25 1.8% | $127M | 49 |
 |
Tenaya TherapeuticsTNYA |
$0.56 4.2% | $130M | 56 |
Explore TuHURA Biosciences Data
Frequently Asked Questions: TuHURA Biosciences (HURA)
TuHURA Biosciences has an AltIndex AI Score of 48/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
48/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of TuHURA Biosciences (HURA) stock is $1.97 with a market cap of $125M.
As of today, TuHURA Biosciences’s PE (Price to Earnings) ratio is —.
View the latest TuHURA Biosciences insider transactions to see recent buying and selling activity by company executives and directors.
Check the TuHURA Biosciences congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The HURA stock price chart above shows TuHURA Biosciences’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full TuHURA Biosciences technical analysis for RSI, moving averages, and more.
See the stocks similar to TuHURA Biosciences section on this page for companies in the same industry ranked by market cap and AI Score.
